» Articles » PMID: 28754015

Human Chorionic Gonadotropin and Breast Cancer

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Jul 30
PMID 28754015
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is well known as a malignancy being strongly influenced by female steroids. Pregnancy is a protective factor against breast cancer. Human chorionic gonadotropin (HCG) is a candidate hormone which could mediate this antitumoral effect of pregnancy. For this review article, all original research articles on the role of HCG in breast cancer were considered, which are listed in PubMed database and were written in English. The role of HCG in breast cancer seems to be a paradox. Placental heterodimeric HCG acts as a protective agent by imprinting a permanent genomic signature of the mammary gland determining a refractory condition to malignant transformation which is characterized by cellular differentiation, apoptosis and growth inhibition. On the other hand, ectopic expression of β-HCG in various cancer entities is associated with poor prognosis due to its tumor-promoting function. Placental HCG and ectopically expressed β-HCG exert opposite effects on breast tumorigenesis. Therefore, mimicking pregnancy by treatment with HCG is suggested as a strategy for breast cancer prevention, whereas targeting β-HCG expressing tumor cells seems to be an option for breast cancer therapy.

Citing Articles

In vitro fertilization impact on the risk of breast cancer.

Mihai A, Ianculescu L, Cretoiu D, Suciu N Arch Clin Cases. 2024; 11(3):73-82.

PMID: 39479256 PMC: 11520175. DOI: 10.22551/2024.44.1103.10292.


BMP4-Induced Suppression of Breast Cancer Metastasis Is Associated with Inhibition of Cholesterol Biosynthesis.

Chi L, Redfern A, Lim Kam Sian T, Street I, Burrows A, Roslan S Int J Mol Sci. 2024; 25(17).

PMID: 39273106 PMC: 11395556. DOI: 10.3390/ijms25179160.


Generation of epitope-specific hCG aptamers through a novel targeted selection approach.

Ferreira L, Flanagan S, Fogel R, Limson J PLoS One. 2024; 19(2):e0295673.

PMID: 38394285 PMC: 10890750. DOI: 10.1371/journal.pone.0295673.


Predisposing and Overall Effects of Reproductive Hormones on Breast Cancer: A Review.

Sarda A, Jogdand S Cureus. 2023; 15(9):e45956.

PMID: 37900385 PMC: 10600026. DOI: 10.7759/cureus.45956.


Quantification of hCG Hormone Using Tapered Optical Fiber Decorated with Gold Nanoparticles.

Villegas-Cantoran D, Gomez C, Gomez-Pavon L, Zaca-Moran P, Castillo-Lopez D, Luis-Ramos A Sensors (Basel). 2023; 23(20).

PMID: 37896633 PMC: 10610987. DOI: 10.3390/s23208538.


References
1.
Sheaff M, Martin J, Badenoch D, Baithun S . beta hCG as a prognostic marker in adenocarcinoma of the prostate. J Clin Pathol. 1996; 49(4):329-32. PMC: 500461. DOI: 10.1136/jcp.49.4.329. View

2.
Agrawal B, Reddish M, Krantz M, Longenecker B . Does pregnancy immunize against breast cancer?. Cancer Res. 1995; 55(11):2257-61. View

3.
Sun X, Nichols H, Tse C, Bell M, Robinson W, Sherman M . Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype. Cancer Epidemiol Biomarkers Prev. 2015; 25(1):60-7. PMC: 4727837. DOI: 10.1158/1055-9965.EPI-15-0864. View

4.
Cole L . Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol. 2010; 8:102. PMC: 2936313. DOI: 10.1186/1477-7827-8-102. View

5.
Anderson B, Petrek J, Byrd D, Senie R, Borgen P . Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger. Ann Surg Oncol. 1996; 3(2):204-11. DOI: 10.1007/BF02305802. View